Odylia Therapeutics Email Format

Biotechnology ResearchGeorgia, United States11-50 Employees

Odylia Therapeutics is a nonprofit biotechnology organization focused on accelerating the development of gene therapies for rare genetic diseases. Based in Atlanta, Georgia, the company aims to bring life-changing treatments to people with genetic conditions regardless of how common or commercially attractive those conditions might be. It operates with a nonprofit model designed to advance therapies from research toward clinical application rather than pursuing traditional profitability. The organization positions itself within the biotechnology research sector by pursuing gene therapies that may benefit patients with limited treatment options, including those affected by Usher syndrome type 1C, and collaborates with allied groups and advisory teams to explore gene-agnostic approaches. 

Recent activity highlights collaborative and research-oriented progress, including partnerships with patient-focused and scientific organizations and formal engagement with advisory networks to pursue potential gene-agnostic therapies. The work is described as targeted toward rare diseases, with ongoing efforts in developing therapies for conditions like Usher syndrome and related genetic disorders. Odylia’s activities reflect a mission-driven, research-first stance within the broader landscape of biotechnology focused on genetic disease treatment in the United States.

Get verified Odylia Therapeutics emails free

Company overview Employee directory